Literature DB >> 2085575

Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study.

K D Serkes1, C R Blagg, K D Nolph, E F Vonesh, F Shapiro.   

Abstract

Patient and technique survival were compared in adult patients new to continuous ambulatory peritoneal dialysis (CAPD) or (primarily) center hemodialysis (HD) in the time period 1981 to 1983, and followed-up in March 1985. Risk factors were identified at entrance into the study, and results were analyzed using Cox's proportional hazards model. For nondiabetic patients, the difference in survival which favored CAPD (relative risk = 0.62) was not significant at the 5% level (p = 0.08). Age was a significant risk factor in both groups. The average number of hospital visits was the same; however, CAPD showed a small but significant increase in average annual hospital days per year (10.14 vs. 9.18). For diabetic patients, there was no significant difference in survival between CAPD and HD. The CAPD group showed a significant increase in hospital visits (relative risk 1.81 vs. 1.40) and average hospital days per year (19.43 vs. 13.41). Both CAPD groups showed significantly higher treatment changeover rates.

Entities:  

Mesh:

Year:  1990        PMID: 2085575

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  15 in total

1.  Changes in patient and technique survival over time among incident peritoneal dialysis patients in Canada.

Authors:  Jeffrey Perl; Ron Wald; Joanne M Bargman; Yingbo Na; S Vanita Jassal; Arsh K Jain; Louise Moist; Sharon J Nessim
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

2.  Selection bias explains apparent differential mortality between dialysis modalities.

Authors:  Robert R Quinn; Janet E Hux; Matthew J Oliver; Peter C Austin; Marcello Tonelli; Andreas Laupacis
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 3.  A comprehensive review on advancements in tissue engineering and microfluidics toward kidney-on-chip.

Authors:  Jasti Sateesh; Koushik Guha; Arindam Dutta; Pratim Sengupta; Dhanya Yalamanchili; Nanda Sai Donepudi; M Surya Manoj; Sk Shahrukh Sohail
Journal:  Biomicrofluidics       Date:  2022-08-16       Impact factor: 3.258

4.  Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis.

Authors:  Robert R Quinn; Pietro Ravani; Xin Zhang; Amit X Garg; Peter G Blake; Peter C Austin; James M Zacharias; John F Johnson; Sanjay Pandeya; Mauro Verrelli; Matthew J Oliver
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

5.  The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): Unifying Efforts to Inform Practice and Improve Global Outcomes in Peritoneal Dialysis.

Authors:  Jeffrey Perl; Simon J Davies; Mark Lambie; Ronald L Pisoni; Keith McCullough; David W Johnson; James A Sloand; Sarah Prichard; Hideki Kawanishi; Francesca Tentori; Bruce M Robinson
Journal:  Perit Dial Int       Date:  2015-11-02       Impact factor: 1.756

6.  Association of dialysis modality and cardiovascular mortality in incident dialysis patients.

Authors:  David W Johnson; Hannah Dent; Carmel M Hawley; Stephen P McDonald; Johan B Rosman; Fiona G Brown; Kym Bannister; Kathryn J Wiggins
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 8.237

7.  Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.

Authors:  David W Johnson; Margaret Clarke; Vanessa Wilson; Feidhlim Woods; Fiona G Brown
Journal:  BMC Nephrol       Date:  2010-09-16       Impact factor: 2.388

8.  Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.

Authors:  Bernard G Jaar; Laura C Plantinga; Deidra C Crews; Nancy E Fink; Nasser Hebah; Josef Coresh; Alan S Kliger; Neil R Powe
Journal:  BMC Nephrol       Date:  2009-02-06       Impact factor: 2.388

9.  The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.

Authors:  David W Johnson; Fiona G Brown; Margaret Clarke; Neil Boudville; Tony J Elias; Marjorie W Y Foo; Bernard Jones; Hemant Kulkarni; Robyn Langham; Dwarakanathan Ranganathan; John Schollum; Michael G Suranyi; Seng H Tan; David Voss
Journal:  Nephrol Dial Transplant       Date:  2012-08-01       Impact factor: 5.992

10.  Peritoneal dialysis outcomes of Indigenous Australian patients of remote Kimberley origin.

Authors:  Julia V Marley; Sarah Moore; Cherelle Fitzclarence; Kevin Warr; David Atkinson
Journal:  Aust J Rural Health       Date:  2014-06       Impact factor: 1.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.